Table of Contents

1 Market Overview
1.1 Overactive Bladder Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Anticholinergics
1.2.2 Mirabegron
1.2.3 Botox
1.3 Market Analysis by Applications
1.3.1 Idiopathic Overactive Bladder
1.3.2 Neurogenic Overactive Bladder
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Business Overview
2.1.2 Overactive Bladder Treatment Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Overactive Bladder Treatment Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Allergan Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Overactive Bladder Treatment Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Pfizer Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva (Activas)
2.4.1 Business Overview
2.4.2 Overactive Bladder Treatment Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Overactive Bladder Treatment Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Overactive Bladder Treatment Market Competition, by Manufacturer
3.1 Global Overactive Bladder Treatment Sales and Market Share by Manufacturer
3.2 Global Overactive Bladder Treatment Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Overactive Bladder Treatment Manufacturer Market Share
3.3.2 Top 6 Overactive Bladder Treatment Manufacturer Market Share
3.4 Market Competition Trend
4 Global Overactive Bladder Treatment Market Analysis by Regions
4.1 Global Overactive Bladder Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Overactive Bladder Treatment Sales by Regions (2012-2017)
4.1.2 Global Overactive Bladder Treatment Revenue by Regions (2012-2017)
4.2 North America Overactive Bladder Treatment Sales and Growth (2012-2017)
4.3 Europe Overactive Bladder Treatment Sales and Growth (2012-2017)
4.4 Asia-Pacific Overactive Bladder Treatment Sales and Growth (2012-2017)
4.5 South America Overactive Bladder Treatment Sales and Growth (2012-2017)
4.6 Middle East and Africa Overactive Bladder Treatment Sales and Growth (2012-2017)
5 North America Overactive Bladder Treatment by Countries
5.1 North America Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Overactive Bladder Treatment Sales by Countries (2012-2017)
5.1.2 North America Overactive Bladder Treatment Revenue by Countries (2012-2017)
5.2 USA Overactive Bladder Treatment Sales and Growth (2012-2017)
5.3 Canada Overactive Bladder Treatment Sales and Growth (2012-2017)
5.4 Mexico Overactive Bladder Treatment Sales and Growth (2012-2017)
6 Europe Overactive Bladder Treatment by Countries
6.1 Europe Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Overactive Bladder Treatment Sales by Countries (2012-2017)
6.1.2 Europe Overactive Bladder Treatment Revenue by Countries (2012-2017)
6.2 Germany Overactive Bladder Treatment Sales and Growth (2012-2017)
6.3 UK Overactive Bladder Treatment Sales and Growth (2012-2017)
6.4 France Overactive Bladder Treatment Sales and Growth (2012-2017)
6.5 Russia Overactive Bladder Treatment Sales and Growth (2012-2017)
6.6 Italy Overactive Bladder Treatment Sales and Growth (2012-2017)
7 Asia-Pacific Overactive Bladder Treatment by Countries
7.1 Asia-Pacific Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Overactive Bladder Treatment Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Overactive Bladder Treatment Revenue by Countries (2012-2017)
7.2 China Overactive Bladder Treatment Sales and Growth (2012-2017)
7.3 Japan Overactive Bladder Treatment Sales and Growth (2012-2017)
7.4 Korea Overactive Bladder Treatment Sales and Growth (2012-2017)
7.5 India Overactive Bladder Treatment Sales and Growth (2012-2017)
7.6 Southeast Asia Overactive Bladder Treatment Sales and Growth (2012-2017)
8 South America Overactive Bladder Treatment by Countries
8.1 South America Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Overactive Bladder Treatment Sales by Countries (2012-2017)
8.1.2 South America Overactive Bladder Treatment Revenue by Countries (2012-2017)
8.2 Brazil Overactive Bladder Treatment Sales and Growth (2012-2017)
8.3 Argentina Overactive Bladder Treatment Sales and Growth (2012-2017)
8.4 Columbia Overactive Bladder Treatment Sales and Growth (2012-2017)
9 Middle East and Africa Overactive Bladder Treatment by Countries
9.1 Middle East and Africa Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Overactive Bladder Treatment Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Overactive Bladder Treatment Revenue by Countries (2012-2017)
9.2 Saudi Arabia Overactive Bladder Treatment Sales and Growth (2012-2017)
9.3 UAE Overactive Bladder Treatment Sales and Growth (2012-2017)
9.4 Egypt Overactive Bladder Treatment Sales and Growth (2012-2017)
9.5 Nigeria Overactive Bladder Treatment Sales and Growth (2012-2017)
9.6 South Africa Overactive Bladder Treatment Sales and Growth (2012-2017)
10 Global Overactive Bladder Treatment Market Segment by Type
10.1 Global Overactive Bladder Treatment Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Overactive Bladder Treatment Sales and Market Share by Type (2012-2017)
10.1.2 Global Overactive Bladder Treatment Revenue and Market Share by Type (2012-2017)
10.2 Anticholinergics Sales Growth and Price
10.2.1 Global Anticholinergics Sales Growth (2012-2017)
10.2.2 Global Anticholinergics Price (2012-2017)
10.3 Mirabegron Sales Growth and Price
10.3.1 Global Mirabegron Sales Growth (2012-2017)
10.3.2 Global Mirabegron Price (2012-2017)
10.4 Botox Sales Growth and Price
10.4.1 Global Botox Sales Growth (2012-2017)
10.4.2 Global Botox Price (2012-2017)
11 Global Overactive Bladder Treatment Market Segment by Application
11.1 Global Overactive Bladder Treatment Sales Market Share by Application (2012-2017)
11.2 Idiopathic Overactive Bladder Sales Growth (2012-2017)
11.3 Neurogenic Overactive Bladder Sales Growth (2012-2017)
12 Overactive Bladder Treatment Market Forecast (2017-2022)
12.1 Global Overactive Bladder Treatment Sales, Revenue and Growth Rate (2017-2022)
12.2 Overactive Bladder Treatment Market Forecast by Regions (2017-2022)
12.2.1 North America Overactive Bladder Treatment Market Forecast (2017-2022)
12.2.2 Europe Overactive Bladder Treatment Market Forecast (2017-2022)
12.2.3 Asia-Pacific Overactive Bladder Treatment Market Forecast (2017-2022)
12.2.4 South America Overactive Bladder Treatment Market Forecast (2017-2022)
12.2.5 Middle East and Africa Overactive Bladder Treatment Market Forecast (2017-2022)
12.3 Overactive Bladder Treatment Market Forecast by Type (2017-2022)
12.4 Overactive Bladder Treatment Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source